《新股消息》ESR(01821.HK)押後在聯交所上市計劃
ESR(01821.HK)公布,公司已決定押後在香港聯交所上市的計劃。公司指,鑒於當前的市況,公司與聯席全球協調人磋商後,決定全球發售將在此刻不予按進行。因此,有關國際發售的國際承銷協議將不會簽訂,而有關香港公開發售的香港承銷協議亦不會成為無條件。
ESR為亞太區最大物流地產平台,公司於6月6日至12日招股,原計劃於6月20日上市。招股價介乎16.2至17.4元,共發行5.61億股,其中2.34億為舊股,5.6%在港作公開發售,德意志銀行和中信里昂為聯席保薦人。以招股價中位數計,集資淨額料約52.74億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.